Four in 10 patients ... [chemotherapy induced peripheral neuropathy] represents a substantial global health challenge, affecting more than 40% of those diagnosed with [it]." Here are four things ...

29, 2025 (HealthDay News) -- Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new evidence review suggests. These patients might experience loss ...

N-AVD treatment in older cHL patients shows high efficacy with 79% progression-free and 97% overall survival rates at three years. The regimen is well-tolerated, with low rates of immune-related side ...

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral ... a new survey has found. Back to top ...

The best multimodal ... perioperative chemotherapy is preferable to preoperative chemoradiotherapy. In this phase 3, multicenter, randomized trial, we assigned in a 1:1 ratio patients with ...